Kanada überträgt weitere Entwicklung NLNK
Seite 2 von 3 Neuester Beitrag: 11.08.23 11:51 | ||||
Eröffnet am: | 19.10.14 18:37 | von: Money is K. | Anzahl Beiträge: | 75 |
Neuester Beitrag: | 11.08.23 11:51 | von: Vassago | Leser gesamt: | 28.709 |
Forum: | Börse | Leser heute: | 4 | |
Bewertet mit: | ||||
Seite: < 1 | | 3 > |
http://seekingalpha.com/news/...rck-ido-competitor-newlink-17-percent
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=10254128
.....darin heisst es :
" Under the terms of the Collaboration Agreement, NewLink will receive an upfront payment of $150 million. NewLink will be eligible to receive in excess of $1 billion in milestone payments based on achievement of certain development, regulatory and sales milestones. In addition, NewLink will receive escalating double-digit percentage royalties on Genentech’s sales of NLG919 and other products resulting from the collaboration. The rates of such royalties will vary based on the stage of the compound at the signing of the Collaboration Agreement, regulatory exclusivity, intellectual property status, and other considerations."
......ein cashgenerator.
also die entwicklung in den nächsten handelstagen sind richtungsweisend.
http://www.ariva.de/newlink_genetics-aktie/...uarter&boerse_id=40
zacks kommentar vom 10.02.2017
https://www.zacks.com/stock/news/248914/...k-continue-to-surge-higher
"Diese Seite zeigt das aktuelle Eigentumsrecht der Gesellschaft durch Institutionen und Fonds sowie aktuelle Änderungen der Positionsgröße. Der Plan 13D zeigt an, dass der Investor mehr als 5% des Unternehmens hält und beabsichtigt, aktiv eine Veränderung in der Geschäftsstrategie zu verfolgen. Zeitplan 13G gibt eine passive Investition von über 5% an. Grüne Reihen zeigen neue Positionen an. Rote Zeilen zeigen geschlossene Positionen an."
https://fintel.io/so/us/nlnk
NLNK
$16.25
*
1.04
6.83%
Read more: http://www.nasdaq.com/symbol/nlnk/real-time#ixzz4ZzsIn4EL
131 mio cash .....
https://seekingalpha.com/pr/...cial-results-updates-indoximod-program
"Net Loss: NewLink Genetics reported a net loss of $16.7 million or ($0.57) per diluted share for the second quarter of 2017 compared to a net loss of $32.4 million or ($1.12) per diluted share for the second quarter of 2016."
http://investors.linkp.com/releasedetail.cfm?ReleaseID=1034912
https://www.sec.gov/Archives/edgar/data/1126234/...70907x8kxex991.htm
Wiedereinstieg:
https://www.fool.com/investing/2018/04/06/...etics-crashed-today.aspx
- Aktienanzahl: 36,8 Mio. $
- Cash zum 31/12/17: 159 Mio. $
- 159 / 36,8 = Cash pro Aktie 4,32 $
- Aktienanzahl: 37,2Mio. $
- Cash zum 31/12/17: 144 Mio. $
- 144 / 37,2 = Cash pro Aktie 3,87 $
http://investors.linkp.com/news-releases/...er-2018-financial-results
https://www.fiercebiotech.com/biotech/...ite-off-ido-yet-says-newlink
NewLink Genetics meldet Zahlen für Q2/18
"The company has completed an organizational realignment that will support these clinical development efforts within its current financial capacity, substantially cut future expenses, and extend its cash runway into the second half of 2021.
The organizational changes include a reduction in headcount of approximately 30% [...]"
http://investors.linkp.com/news-releases/...an-reports-second-quarter
https://seekingalpha.com/article/...l-healthcare-conference-slideshow